Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Antibody-Drug Conjugates (ADCs) represent a novel class of therapeutics that have garnered significant attention over the past decade, particularly in the field of oncology. These conjugates are designed to deliver cytotoxic drugs specifically to tumor cells, thereby minimizing damage to normal tissues. ADCs are composed of a monoclonal antibody linked to a potent drug via a specialized linker. This design leverages the specificity of antibodies to target antigens that are overexpressed or uniquely expressed on tumor cells.